NRX Pharmaceuticals (NRXP) Change in Cash (2017 - 2026)

NRX Pharmaceuticals (NRXP) has 10 years of Change in Cash data on file, last reported at -$1.1 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 126.41% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 72.45% decrease from a year earlier, with the FY2025 full-year figure at $6.4 million, up 301.59% from the prior year.
• Change in Cash for Q1 2026 stood at -$1.1 million, down from $613000.0 in the prior quarter.
• Over the last five years, Change in Cash for NRXP reached as high as $12.6 million in Q1 2022 and fell as low as -$15.7 million in Q2 2022.
• Historically, Change in Cash has averaged -$1.2 million across 5 years, with a median of -$1.1 million in 2026.
• Across the five-year window, Change in Cash slumped 13712.17% in 2022 and jumped 1796.03% in 2025, its largest moves.
• Year by year, Change in Cash stood at $1.8 million in 2022, then slumped by 338.61% to -$4.3 million in 2023, then surged by 95.29% to -$203000.0 in 2024, then jumped by 401.97% to $613000.0 in 2025, then tumbled by 276.84% to -$1.1 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$1.1 million in Q1 2026, $613000.0 in Q4 2025, and $4.3 million in Q3 2025.